Please login to the form below

US drug pricing

This page shows the latest US drug pricing news and features for those working in and with pharma, biotech and healthcare.

Pfizer, Sanofi and others set to increase US drug prices in 2021

Drug pricing will also be a focus of the incoming President-elect, Joe Biden, who has promised to reduce drug prices in the US. ... Despite the ongoing debate around drug pricing in the US Congress, it is expected that further drug price increases are to

Latest news

Lilly joins new Medicare scheme to reduce insulin prices

New model will cover seniors enrolled in Medicare Part D. Eli Lilly, one of the largest manufacturers of insulin in the US, has announced it will join a new Medicare scheme ... These rising costs have also caught the attention of the US government, which
FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging

The US Food and Drug Administration (FDA) has approved the first generic of Daraprim, a decades-old drug for the treatment of toxoplasmosis that hit the headlines in 2015 after its ... Gaming tactics include preventing generic drugmakers getting samples
US start-up EQRx promises approach that will slash drug prices

A new US start-up says it has a plan to completely revamp the approach to drug development, allowing to launch drugs more quickly and at a lower cost. ... Bach recently proposed a model for selecting drugs for pricing negotiations with Medicare – a
GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

range. The price increases come amid intense public and political discourse over prescription drug prices in the US. ... The draft guidance would allow states in the US to import prescription drugs from Canada, as part of cost-saving efforts to combat
Trump administration advances drug importation plan

The drug prices in Canada and its provinces are much lower than those in the US, due to tighter price regulations and governmental negotiations with drug companies. ... There is no way that pharma sells more drug to Canada so that the US can import at

More from news
Approximately 11 fully matching, plus 33 partially matching documents found.

Latest Intelligence

The Golden Goose

Why it’s so hard for the US to curb runaway drug prices. ... Something that is seldom mentioned in the drug pricing debate: the US has a greater number of generics sold at cheaper prices than any other country in the world, with 90%